Banerji U, O'Donnell A, Scurr M, et al. Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies. J Clin Oncol 2005; 23: 4152–61. 15. Neckers L, Neckers K. Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents.
Protein C is a naturally occurring anti-coagulant with key pathways that are beneficial in the treatment of sepsis; such as the cytoprotective mechanisms which include ant... ... middle of paper ... ...cts of recombinant human activated protein C in a ewe model of septic shock. Crit Care Med. ;35(11):2594-600. van Deventer SJH, Bluller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. (1990) Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood.
Meta-Analysis. Retrieved by http://explorable.com/meta-analysis Starke, R.M., Komotar, R.J., Hwang, B.Y., Fischer, L.E., Garret, M.C., Otten, M.L., … Connolly, E.S. (2009). Treatment Guidelines for Cerebral Arteriovenous Malformation Microsurgery. British Journal of Neurosurgery, 23(4), 376-386. doi: 10.1080/02688690902977662 Yen, C., Sheehan, J.P., Schwyzer, L., Schlesinger, D. (2011).
Neurology 1988; 38(suppl 2): 14-18. Weiner HL, Mackin GA, Orva EJ, et al. Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group. Neurology 1991: 41: 1047.
Shenkin H, Bezier H, & Bouzarth W. (1976). Restricted fluid intake: rational management of the neurosurgical patient. Journal of Neurosurgery, 45 (4), 432–36. Simma B, Burga R, Falk M, Sacher P, & Fanconi S. (1998) A prospective, randomized, and controlled study of fluid management in children with severe head injury: lactated ringer’s solution versus hypertonic saline. Critical Care Medicine, 26(7), 1265–70.